Nuventra Pharma Sciences, a United States-based clinical pharmacology consulting company, has named Daniel Roy, MHA as its new president, it was reported on Tuesday.
Roy joined the company in 2014 as manager of Marketing and Corporate Communication. He has served in various roles of increasing responsibility including senior director of Business Development and Marketing, and most recently as vice president of Corporate Strategy and Business Development. He has 16 years of experience in leadership, marketing, and business development. He will continue to serve as the company's chief executive officer.
Roy graduated from Ohio University with a Master of Healthcare Administration and acquired a Bachelor of Arts degree in Communication from East Carolina University.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business